Skip to content
Tech News
← Back to articles

McDonald's plans smaller portions, protein-focused menu items

read original more articles
GoKawiil Brief

McDonald's is developing new menu options including grilled chicken, wraps and egg bites, alongside smaller portion sizes. The company points to roughly 30 million Americans now using GLP-1 weight-loss drugs as a factor shaping demand for its food offerings.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

The shift suggests fast-food chains are beginning to adjust their menus as GLP-1 drugs like Ozempic change how a large segment of consumers eat, potentially reducing appetite for large, calorie-dense meals. If GLP-1 use continues to grow, other restaurant chains could face similar pressure to rework their offerings to retain customers.

Key Takeaways

Source: fastcompany.com, 2026-09-25

Published there as: “McDonald’s is changing its menu for the Ozempic era”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.